These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Clinical and cell biological features related to cellular drug resistance of childhood acute lymphoblastic leukemia cells. Kaspers GJ, Pieters R, Van Zantwijk CH, Van Wering ER, Veerman AJ. Leuk Lymphoma; 1995 Nov; 19(5-6):407-16. PubMed ID: 8590840 [Abstract] [Full Text] [Related]
7. Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia. Pieters R, Huismans DR, Loonen AH, Hählen K, van der Does-van den Berg A, van Wering ER, Veerman AJ. Lancet; 1991 Aug 17; 338(8764):399-403. PubMed ID: 1678081 [Abstract] [Full Text] [Related]
8. In vitro cytotoxicity of mitoxantrone, daunorubicin and doxorubicin in untreated childhood acute leukemia. Kaspers GL, Veerman AJ, Pieters R, van Zantwijk I, Klumper E, Hählen K, de Waal FC, van Wering ER. Leukemia; 1994 Jan 17; 8(1):24-9. PubMed ID: 8289494 [Abstract] [Full Text] [Related]
9. In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study Groups. Ramakers-van Woerden NL, Pieters R, Hoelzer D, Slater RM, den Boer ML, Loonen AH, Harbott J, Janka-Schaub GE, Ludwig WD, Ossenkoppele GJ, van Wering ER, Veerman AJ, Dutch and German Leukemia Study Groups. Med Pediatr Oncol; 2002 Jun 17; 38(6):379-86. PubMed ID: 11984797 [Abstract] [Full Text] [Related]
10. Biological characteristics and prognostic value of in vitro three-drug resistance to prednisolone, L-asparaginase, and vincristine in childhood acute lymphoblastic leukemia. Hongo T, Yamada S, Yajima S, Watanabe C, Fujii Y, Kawasaki H, Yazaki M, Hanada R, Horikoshi Y. Int J Hematol; 1999 Dec 17; 70(4):268-77. PubMed ID: 10643153 [Abstract] [Full Text] [Related]
13. Comparison of prognostic value of in vitro drug resistance and bone marrow residual disease on day 15 of therapy in childhood acute lymphoblastic leukemia. Styczynski J, Piatkowska M, Jaworska-Posadzy A, Czyzewski K, Kubicka M, Kolodziej B, Kurylo-Rafinska B, Debski R, Pogorzala M, Wysocki M. Anticancer Res; 2012 Dec 17; 32(12):5495-9. PubMed ID: 23225457 [Abstract] [Full Text] [Related]
15. In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia. Styczynski J, Pieters R, Huismans DR, Schuurhuis GJ, Wysocki M, Veerman AJ. Br J Haematol; 2000 Sep 17; 110(4):813-8. PubMed ID: 11054062 [Abstract] [Full Text] [Related]
16. Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Medical Research Council Childhood Leukaemia Working Party. Hann IM, Richards SM, Eden OB, Hill FG. Leukemia; 1998 Aug 17; 12(8):1249-55. PubMed ID: 9697880 [Abstract] [Full Text] [Related]
17. Adenosine deaminase and purine nucleoside phosphorylase in childhood lymphoblastic leukemia: relation with differentiation stage, in vitro drug resistance and clinical prognosis. Pieters R, Huismans DR, Loonen AH, Peters GJ, Hählen K, van der Does-van den Berg A, van Wering ER, Veerman AJ. Leukemia; 1992 May 17; 6(5):375-80. PubMed ID: 1593902 [Abstract] [Full Text] [Related]
19. Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: a preliminary report. Kaspers GJ, Kardos G, Pieters R, Van Zantwijk CH, Klumper E, Hählen K, de Waal FC, van Wering ER, Veerman AJ. Leukemia; 1994 Jul 17; 8(7):1224-9. PubMed ID: 8035616 [Abstract] [Full Text] [Related]
20. Corticosteroid resistance is increased in lymphoblasts from adults compared with children: preliminary results of in vitro drug sensitivity study in adults with acute lymphoblastic leukaemia. Maung ZT, Reid MM, Matheson E, Taylor PR, Proctor SJ, Hall AG. Br J Haematol; 1995 Sep 17; 91(1):93-100. PubMed ID: 7577660 [Abstract] [Full Text] [Related] Page: [Next] [New Search]